Thought Leadership & Other Media

AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021

Events Cell & Gene Therapy Virtual Site Tour

Since 2013, European Biotech Week has been a premier event offering exclusive content, meetings and demonstrations that highlight how biotech can improve our quality of life. 
 
This year, we are excited to partner with European Biotech Week 2021 to open the doors of our expanded state-of-the-art Cell and Gene Therapy Center of Excellence and production facility in Milan, Italy. 
As a global CDMO, we are laser-focused on building the industry’s best cell and gene therapy (C&GT) and biologics development and manufacturing services. 
On October 1st at 11:00 am CET, AGC Biologics is hosting a free virtual tour that showcases our end-to-end capabilities and our new Process Development and Quality Control laboratories. 
 
You don’t want to miss it, sign-up today! 

AGC Biologics is Attending BIO Asia-Taiwan July 23-26, 2021 Presenting Our Biological and Cell & Gene Therapy Capabilities

Thought Leadership Cell & Gene Therapy Biological Solutions

We're pleased to announce that we will be attending BIO Asia-Taiwan Exhibition running virtually from July 23 through 26. Be sure to save some time to meet with our team, check out our presentations on Biological and Cell & Gene Therapy offerings – which we're thrilled to share with you and the community.  
 
Can't attend this year? Check-in back here after the conference and we'll upload our presentation and key takeaways right here in this blog.

Webinar: Large-Scale AAV Manufacturing: The Road from Concept to Ready-to-Use Platform

Thought Leadership Cell & Gene Therapy

It's with tremendous excitement that we announce the webinar and live Q&A session, titled “Large-Scale AAV Manufacturing: The Road from Concept to Ready-to-Use Platform” will be held Wednesday, May 26th at 8:00 AM PDT / 5:00 pm CEST.  This webinar will be co-presented by Margherita Neri, Upstream Vector Process Development Manager, AGC Biologics, and Claire Wartel, Director of Quality and Compliance, Polyplus-Transfection.

AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data

Events Cell & Gene Therapy

We're pleased to announce that we will be attending ASGCT this year, running virtually from May 11 through the 14. Be sure to save some time to meet with our team, check out our two abstracts and presentations on lentiviral vector (LVV) and adeno-associated virus (AAV) – both of which we're thrilled to share with you and the community.  

On-Demand Webinar: Large-Scale LVV Production: Industry-Leading Process Development to High Quality GMP Vector

Thought Leadership Cell & Gene Therapy

The on-demand webinar and Q&A “Large-Scale LVV Production: From Industry-Leading Process Development to High Quality GMP Vector,” with our own Giuliana Vallanti, Director of Development and Global R&D, Cell and Gene Therapy, and the panel of co-hosts is now available to watch for free.

On-Demand Roundtable: Streaming and Optimizing Viral Vector Bioprocess and Analytical Development

Thought Leadership Cell & Gene Therapy

Join AGC Biologics' own Mark Womack, Chief Business Officer and Ramin Baghirzade, Sr. Director and Global Cell and Gene Therapy (C&GT) Business Development, and a panel of co-hosts for an on-demand presentation of the C&GT Expert Roundtable on Streaming and Optimizing Viral Vector Bioprocess and Analytical Development, presented by BioInsights.

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Events Thought Leadership Cell & Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 

Article: Process Development: How to Win the Race in Cell & Gene Therapy

Thought Leadership Cell & Gene Therapy

In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.

Follow Us
Join us on LinkedIn Follow us on Twitter